IM Cannabis (IMCC) Operating Margin (2020 - 2026)
IM Cannabis (IMCC) posted quarterly Operating Margin of 19.31% for Q1 2026, down 2057.0% year-over-year from 0.99% in Q1 2025, and up 58.18% quarter-over-quarter from 46.17% in Q4 2025.
IM Cannabis (IMCC) Operating Margin (2020 - 2026) Analysis & Trends
IM Cannabis' Operating Margin history runs 7 years deep, the most recent figure standing at 19.31% for Q1 2026.
- In Q1 2026, Operating Margin fell 2057.0% year-over-year to 19.31%; the TTM figure through Mar 2026 stood at 26.32% (down 1804.0% YoY), while the FY2025 annual figure was 21.17%, down 223.0% from the prior year.
- Operating Margin for Q1 2026 stood at 19.31%, up from 46.17% in the prior quarter.
- The five-year high for Operating Margin was 83.84% in Q1 2022, with the low at 351.79% in Q4 2022.
- The 5-year median for Operating Margin is 5.86% (2024), against an average of 28.88%.
- The sharpest annual moves came in 2022 and 2024: Operating Margin plunged 30722 bps in 2022, then jumped 18500 bps in 2024.
- IM Cannabis' Operating Margin stood at 351.79% in 2022, then soared by 46 bps to 190.87% in 2023, then soared by 97 bps to 5.86% in 2024, then sank by 687 bps to 46.17% in 2025, then surged by 58 bps to 19.31% in 2026.
- Business Quant data shows IMCC's Operating Margin at 19.31% in Q1 2026, 46.17% in Q4 2025, and 29.98% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | IM Cannabis | 537,472.00 | -631,498.17 | 1.09 Mn | -27.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.54% |
| Mar 31, 2026 | -19.31% |
| Dec 31, 2025 | -46.17% |
| Sep 30, 2025 | -29.98% |
| Jun 30, 2025 | -2.76% |
| Mar 31, 2025 | 1.26% |
| Dec 31, 2024 | -5.86% |
| Sep 30, 2024 | -6.86% |
| Jun 30, 2024 | -19.45% |
| Mar 31, 2024 | -46.67% |
| Dec 31, 2023 | -190.87% |
| Sep 30, 2023 | 18.26% |
| Jun 30, 2023 | 13.27% |
| Mar 31, 2023 | 28.87% |
| Dec 31, 2022 | -351.79% |
| Sep 30, 2022 | 39.00% |
| Jun 30, 2022 | 44.27% |
| Mar 31, 2022 | 83.84% |
| Dec 31, 2021 | -44.57% |
| Sep 30, 2021 | -96.35% |